J Allergy Clin Immunol Pract
February 2021
Background: Patients with multiple drug allergy labels (MDALs) present a challenging barrier to patient care.
Objective: To assess the efficacy, safety, and effectiveness of removing MDALs in a single clinic visit.
Methods: Retrospective chart review was performed from October 1, 2014, to October 31, 2018, on patients with MDALs who had electronic health record (EHR) allergy label to 2 or more drugs and who were delabeled to 1 or more drug.
Neuroendocrine carcinomas (NECs) of the esophagus are very rare. The majority of the patients with NECs present with metastasis. Paraneoplastic syndromes, such as syndrome of inappropriate secretion of anti-diuretic hormone and watery diarrhea-hypokalemia-achlorhydria syndrome, have been reported in previous reports.
View Article and Find Full Text PDF